Eintrag weiter verarbeiten
A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model
Gespeichert in:
| Zeitschriftentitel: | Scientific Reports |
|---|---|
| Personen und Körperschaften: | , , , , , , , , , , |
| In: | Scientific Reports, 7, 2017, 1 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Springer Science and Business Media LLC
|
| Schlagwörter: |
| author_facet |
Brault, Aaron C. Domi, Arban McDonald, Erin M. Talmi-Frank, Dalit McCurley, Nathanael Basu, Rahul Robinson, Harriet L. Hellerstein, Michael Duggal, Nisha K. Bowen, Richard A. Guirakhoo, Farshad Brault, Aaron C. Domi, Arban McDonald, Erin M. Talmi-Frank, Dalit McCurley, Nathanael Basu, Rahul Robinson, Harriet L. Hellerstein, Michael Duggal, Nisha K. Bowen, Richard A. Guirakhoo, Farshad |
|---|---|
| author |
Brault, Aaron C. Domi, Arban McDonald, Erin M. Talmi-Frank, Dalit McCurley, Nathanael Basu, Rahul Robinson, Harriet L. Hellerstein, Michael Duggal, Nisha K. Bowen, Richard A. Guirakhoo, Farshad |
| spellingShingle |
Brault, Aaron C. Domi, Arban McDonald, Erin M. Talmi-Frank, Dalit McCurley, Nathanael Basu, Rahul Robinson, Harriet L. Hellerstein, Michael Duggal, Nisha K. Bowen, Richard A. Guirakhoo, Farshad Scientific Reports A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model Multidisciplinary |
| author_sort |
brault, aaron c. |
| spelling |
Brault, Aaron C. Domi, Arban McDonald, Erin M. Talmi-Frank, Dalit McCurley, Nathanael Basu, Rahul Robinson, Harriet L. Hellerstein, Michael Duggal, Nisha K. Bowen, Richard A. Guirakhoo, Farshad 2045-2322 Springer Science and Business Media LLC Multidisciplinary http://dx.doi.org/10.1038/s41598-017-15039-8 <jats:title>Abstract</jats:title><jats:p>Zika virus (ZIKV) is a mosquito-borne flavivirus that has rapidly extended its geographic range around the world. Its association with abnormal fetal brain development, sexual transmission, and lack of a preventive vaccine have constituted a global health concern. Designing a safe and effective vaccine requires significant caution due to overlapping geographical distribution of ZIKV with dengue virus (DENV) and other flaviviruses, possibly resulting in more severe disease manifestations in flavivirus immune vaccinees such as Antibody-Dependent Enhancement (ADE, a phenomenon involved in pathogenesis of DENV, and a risk associated with ZIKV vaccines using the envelope proteins as immunogens). Here, we describe the development of an alternative vaccine strategy encompassing the expression of ZIKV non-structural-1 (NS1) protein from a clinically proven safe, Modified Vaccinia Ankara (MVA) vector, thus averting the potential risk of ADE associated with structural protein-based ZIKV vaccines. A single intramuscular immunization of immunocompetent mice with the MVA-ZIKV-NS1 vaccine candidate provided robust humoral and cellular responses, and afforded 100% protection against a lethal intracerebral dose of ZIKV (strain MR766). This is the first report of (i) a ZIKV vaccine based on the NS1 protein and (ii) single dose protection against ZIKV using an immunocompetent lethal mouse challenge model.</jats:p> A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model Scientific Reports |
| doi_str_mv |
10.1038/s41598-017-15039-8 |
| facet_avail |
Online Free |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAzOC9zNDE1OTgtMDE3LTE1MDM5LTg |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAzOC9zNDE1OTgtMDE3LTE1MDM5LTg |
| institution |
DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 |
| imprint |
Springer Science and Business Media LLC, 2017 |
| imprint_str_mv |
Springer Science and Business Media LLC, 2017 |
| issn |
2045-2322 |
| issn_str_mv |
2045-2322 |
| language |
English |
| mega_collection |
Springer Science and Business Media LLC (CrossRef) |
| match_str |
brault2017azikavaccinetargetingns1proteinprotectsimmunocompetentadultmiceinalethalchallengemodel |
| publishDateSort |
2017 |
| publisher |
Springer Science and Business Media LLC |
| recordtype |
ai |
| record_format |
ai |
| series |
Scientific Reports |
| source_id |
49 |
| title |
A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model |
| title_unstemmed |
A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model |
| title_full |
A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model |
| title_fullStr |
A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model |
| title_full_unstemmed |
A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model |
| title_short |
A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model |
| title_sort |
a zika vaccine targeting ns1 protein protects immunocompetent adult mice in a lethal challenge model |
| topic |
Multidisciplinary |
| url |
http://dx.doi.org/10.1038/s41598-017-15039-8 |
| publishDate |
2017 |
| physical |
|
| description |
<jats:title>Abstract</jats:title><jats:p>Zika virus (ZIKV) is a mosquito-borne flavivirus that has rapidly extended its geographic range around the world. Its association with abnormal fetal brain development, sexual transmission, and lack of a preventive vaccine have constituted a global health concern. Designing a safe and effective vaccine requires significant caution due to overlapping geographical distribution of ZIKV with dengue virus (DENV) and other flaviviruses, possibly resulting in more severe disease manifestations in flavivirus immune vaccinees such as Antibody-Dependent Enhancement (ADE, a phenomenon involved in pathogenesis of DENV, and a risk associated with ZIKV vaccines using the envelope proteins as immunogens). Here, we describe the development of an alternative vaccine strategy encompassing the expression of ZIKV non-structural-1 (NS1) protein from a clinically proven safe, Modified Vaccinia Ankara (MVA) vector, thus averting the potential risk of ADE associated with structural protein-based ZIKV vaccines. A single intramuscular immunization of immunocompetent mice with the MVA-ZIKV-NS1 vaccine candidate provided robust humoral and cellular responses, and afforded 100% protection against a lethal intracerebral dose of ZIKV (strain MR766). This is the first report of (i) a ZIKV vaccine based on the NS1 protein and (ii) single dose protection against ZIKV using an immunocompetent lethal mouse challenge model.</jats:p> |
| container_issue |
1 |
| container_start_page |
0 |
| container_title |
Scientific Reports |
| container_volume |
7 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792343168748879877 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T16:46:57.92Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=A+Zika+Vaccine+Targeting+NS1+Protein+Protects+Immunocompetent+Adult+Mice+in+a+Lethal+Challenge+Model&rft.date=2017-11-07&genre=article&issn=2045-2322&volume=7&issue=1&jtitle=Scientific+Reports&atitle=A+Zika+Vaccine+Targeting+NS1+Protein+Protects+Immunocompetent+Adult+Mice+in+a+Lethal+Challenge+Model&aulast=Guirakhoo&aufirst=Farshad&rft_id=info%3Adoi%2F10.1038%2Fs41598-017-15039-8&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792343168748879877 |
| author | Brault, Aaron C., Domi, Arban, McDonald, Erin M., Talmi-Frank, Dalit, McCurley, Nathanael, Basu, Rahul, Robinson, Harriet L., Hellerstein, Michael, Duggal, Nisha K., Bowen, Richard A., Guirakhoo, Farshad |
| author_facet | Brault, Aaron C., Domi, Arban, McDonald, Erin M., Talmi-Frank, Dalit, McCurley, Nathanael, Basu, Rahul, Robinson, Harriet L., Hellerstein, Michael, Duggal, Nisha K., Bowen, Richard A., Guirakhoo, Farshad, Brault, Aaron C., Domi, Arban, McDonald, Erin M., Talmi-Frank, Dalit, McCurley, Nathanael, Basu, Rahul, Robinson, Harriet L., Hellerstein, Michael, Duggal, Nisha K., Bowen, Richard A., Guirakhoo, Farshad |
| author_sort | brault, aaron c. |
| container_issue | 1 |
| container_start_page | 0 |
| container_title | Scientific Reports |
| container_volume | 7 |
| description | <jats:title>Abstract</jats:title><jats:p>Zika virus (ZIKV) is a mosquito-borne flavivirus that has rapidly extended its geographic range around the world. Its association with abnormal fetal brain development, sexual transmission, and lack of a preventive vaccine have constituted a global health concern. Designing a safe and effective vaccine requires significant caution due to overlapping geographical distribution of ZIKV with dengue virus (DENV) and other flaviviruses, possibly resulting in more severe disease manifestations in flavivirus immune vaccinees such as Antibody-Dependent Enhancement (ADE, a phenomenon involved in pathogenesis of DENV, and a risk associated with ZIKV vaccines using the envelope proteins as immunogens). Here, we describe the development of an alternative vaccine strategy encompassing the expression of ZIKV non-structural-1 (NS1) protein from a clinically proven safe, Modified Vaccinia Ankara (MVA) vector, thus averting the potential risk of ADE associated with structural protein-based ZIKV vaccines. A single intramuscular immunization of immunocompetent mice with the MVA-ZIKV-NS1 vaccine candidate provided robust humoral and cellular responses, and afforded 100% protection against a lethal intracerebral dose of ZIKV (strain MR766). This is the first report of (i) a ZIKV vaccine based on the NS1 protein and (ii) single dose protection against ZIKV using an immunocompetent lethal mouse challenge model.</jats:p> |
| doi_str_mv | 10.1038/s41598-017-15039-8 |
| facet_avail | Online, Free |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAzOC9zNDE1OTgtMDE3LTE1MDM5LTg |
| imprint | Springer Science and Business Media LLC, 2017 |
| imprint_str_mv | Springer Science and Business Media LLC, 2017 |
| institution | DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275 |
| issn | 2045-2322 |
| issn_str_mv | 2045-2322 |
| language | English |
| last_indexed | 2024-03-01T16:46:57.92Z |
| match_str | brault2017azikavaccinetargetingns1proteinprotectsimmunocompetentadultmiceinalethalchallengemodel |
| mega_collection | Springer Science and Business Media LLC (CrossRef) |
| physical | |
| publishDate | 2017 |
| publishDateSort | 2017 |
| publisher | Springer Science and Business Media LLC |
| record_format | ai |
| recordtype | ai |
| series | Scientific Reports |
| source_id | 49 |
| spelling | Brault, Aaron C. Domi, Arban McDonald, Erin M. Talmi-Frank, Dalit McCurley, Nathanael Basu, Rahul Robinson, Harriet L. Hellerstein, Michael Duggal, Nisha K. Bowen, Richard A. Guirakhoo, Farshad 2045-2322 Springer Science and Business Media LLC Multidisciplinary http://dx.doi.org/10.1038/s41598-017-15039-8 <jats:title>Abstract</jats:title><jats:p>Zika virus (ZIKV) is a mosquito-borne flavivirus that has rapidly extended its geographic range around the world. Its association with abnormal fetal brain development, sexual transmission, and lack of a preventive vaccine have constituted a global health concern. Designing a safe and effective vaccine requires significant caution due to overlapping geographical distribution of ZIKV with dengue virus (DENV) and other flaviviruses, possibly resulting in more severe disease manifestations in flavivirus immune vaccinees such as Antibody-Dependent Enhancement (ADE, a phenomenon involved in pathogenesis of DENV, and a risk associated with ZIKV vaccines using the envelope proteins as immunogens). Here, we describe the development of an alternative vaccine strategy encompassing the expression of ZIKV non-structural-1 (NS1) protein from a clinically proven safe, Modified Vaccinia Ankara (MVA) vector, thus averting the potential risk of ADE associated with structural protein-based ZIKV vaccines. A single intramuscular immunization of immunocompetent mice with the MVA-ZIKV-NS1 vaccine candidate provided robust humoral and cellular responses, and afforded 100% protection against a lethal intracerebral dose of ZIKV (strain MR766). This is the first report of (i) a ZIKV vaccine based on the NS1 protein and (ii) single dose protection against ZIKV using an immunocompetent lethal mouse challenge model.</jats:p> A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model Scientific Reports |
| spellingShingle | Brault, Aaron C., Domi, Arban, McDonald, Erin M., Talmi-Frank, Dalit, McCurley, Nathanael, Basu, Rahul, Robinson, Harriet L., Hellerstein, Michael, Duggal, Nisha K., Bowen, Richard A., Guirakhoo, Farshad, Scientific Reports, A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model, Multidisciplinary |
| title | A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model |
| title_full | A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model |
| title_fullStr | A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model |
| title_full_unstemmed | A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model |
| title_short | A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model |
| title_sort | a zika vaccine targeting ns1 protein protects immunocompetent adult mice in a lethal challenge model |
| title_unstemmed | A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model |
| topic | Multidisciplinary |
| url | http://dx.doi.org/10.1038/s41598-017-15039-8 |